Login / Signup

CREPT/RPRD1B associates with Aurora B to regulate Cyclin B1 expression for accelerating the G2/M transition in gastric cancer.

Lidan DingLiu YangJianqiu ShengBingtao ZhuFangli RenXuanzi FanYinyin WangMengdi LiJun LiYanshen KuangSihan LiuWanli ZhaiDanhui MaYanfang JuQuentin LiuBaoqing JiaJianqiu ShengZhijie Chang
Published in: Cell death & disease (2018)
Gastric cancer, like most of other cancers, has an uncontrolled cell cycle regulated by cyclins and cyclin-dependent kinases (CDKs). In this study, we reported that gastric cancer cells showed an accelerated G2/M transition promoted by CREPT/RPRD1B and Aurora kinase B (Aurora B). We found that CREPT/RPRD1B and Aurora B were coordinately expressed during the cell cycle in gastric cancer cells. Deletion of CREPT/RPRD1B disturbed the cell progression and extended the length of cell cycle, leading to a significant accumulation of mitotic cells. Mechanistically, we revealed that CREPT/RPRD1B interacted with Aurora B to regulate the expression of Cyclin B1 in gastric cancer cells. Interestingly, Aurora B phosphorylates S145 in a well-conserved motif of CREPT/RPRD1B. We proposed that phosphorylation of CREPT/RPRD1B by Aurora B is required for promoting the transcription of Cyclin B1, which is critical for the regulation of gastric tumorigenesis. Our study provides a mechanism by which gastric tumor cells maintain their high proliferation rate via coordination of Aurora B and CREPT/RPRD1B on the expression of Cyclin B1. Targeting the interaction of Aurora B and CREPT/RPRD1B might be a strategy for anti-gastric cancer therapy in the future.
Keyphrases
  • cell cycle
  • cell proliferation
  • poor prognosis
  • cancer therapy
  • induced apoptosis
  • transcription factor
  • cell cycle arrest
  • binding protein
  • bone marrow
  • mesenchymal stem cells
  • young adults
  • pi k akt